Significant Immune Findings in Periodontal Diseases

Periodontal diseases are associated with various immune responses that can influence disease progression and severity. Understanding these immune findings is crucial for diagnosing and managing different forms of periodontal disease.

Immune Findings in Specific Periodontal Diseases

1. Acute Necrotizing Ulcerative Gingivitis (ANUG):

   • Findings:
     • PMN (Polymorphonuclear neutrophil) chemotactic defect: This defect impairs the ability of neutrophils to migrate to the site of infection, compromising the immune response.
     • Elevated antibody titres to Prevotella intermedia and intermediate-sized spirochetes: Indicates an immune response to specific pathogens associated with the disease.

2. Pregnancy Gingivitis:

   • Findings:
     • No significant immune findings reported: While pregnancy gingivitis is common, it does not show distinct immune abnormalities compared to other forms of periodontal disease.

3. Adult Periodontitis:

   • Findings:
     • Elevated antibody titres to Porphyromonas gingivalis and other periodontopathogens: Suggests a heightened immune response to these specific bacteria.
     • Occurrence of immune complexes in tissues: Indicates an immune reaction that may contribute to tissue damage.
     • Immediate hypersensitivity to gingival bacteria: Reflects an exaggerated immune response to bacterial antigens.
     • Cell-mediated immunity to gingival bacteria: Suggests involvement of T-cells in the immune response against periodontal pathogens.

4. Juvenile Periodontitis:

   • Localized Juvenile Periodontitis (LJP):
     • Findings:
       • PMN chemotactic defect and depressed phagocytosis: Impairs the ability of neutrophils to respond effectively to bacterial invasion.
       • Elevated antibody titres to Actinobacillus actinomycetemcomitans: Indicates an immune response to this specific pathogen.
   • Generalized Juvenile Periodontitis (GJP):
     • Findings:
       • PMN chemotactic defect and depressed phagocytosis: Similar to LJP, indicating a compromised immune response.
       • Elevated antibody titres to Porphyromonas gingivalis: Suggests an immune response to this pathogen.

5. Prepubertal Periodontitis:

   • Findings:
     • PMN chemotactic defect and depressed phagocytosis: Indicates impaired neutrophil function.
     • Elevated antibody titres to Actinobacillus actinomycetemcomitans: Suggests an immune response to this pathogen.

6. Rapid Periodontitis:

   • Findings:
     • Suppressed or enhanced PMN or monocyte chemotaxis: Indicates variability in immune response among individuals.
     • Elevated antibody titres to several gram-negative bacteria: Reflects an immune response to multiple pathogens.

7. Refractory Periodontitis:

   • Findings:
     • Reduced PMN chemotaxis: Indicates impaired neutrophil migration, which may contribute to disease persistence despite treatment.

8. Desquamative Gingivitis:

   • Findings:
     • Diagnostic or characteristic immunopathology in two-thirds of cases: Suggests an underlying immune mechanism.
     • Autoimmune etiology in cases resulting from pemphigus and pemphigoid: Indicates that some cases may be due to autoimmune processes affecting the gingival tissue.

Dark Field Microscopy in Periodontal Microbiology

Dark field microscopy and phase contrast microscopy are valuable techniques in microbiological studies, particularly in the field of periodontal research. These methods allow for the direct observation of bacteria in plaque samples, providing insights into their morphology and motility. This lecture will discuss the principles of dark field microscopy, its applications in periodontal disease assessment, and its limitations.

Dark Field Microscopy

• Definition: Dark field microscopy is a technique that enhances the contrast of unstained, transparent specimens, allowing for the visualization of live microorganisms in their natural state.
• Principle: The method uses a special condenser that directs light at an angle, creating a dark background against which the specimen appears bright. This allows for the observation of motility and morphology without the need for staining.

Applications in Periodontal Microbiology

1. Alternative to Culture Methods:

   • Dark field microscopy has been suggested as a rapid alternative to traditional culture methods for assessing bacterial populations in periodontal plaque samples. It allows for immediate observation of bacteria without the time-consuming process of culturing.

2. Assessment of Morphology and Motility:

   • The technique enables direct and rapid assessment of the morphology (shape and structure) and motility (movement) of bacteria present in plaque samples. This information can be crucial for understanding the dynamics of periodontal disease.

3. Indication of Periodontal Disease Status:

   • Dark field microscopy has been used to indicate the status of periodontal disease and the effectiveness of maintenance programs. By observing the presence and activity of specific bacteria, clinicians can gain insights into the health of periodontal tissues.

Limitations of Dark Field Microscopy

1. Analysis of Major Periodontal Pathogens:

   • While dark field microscopy can visualize motile bacteria, it is important to note that many major periodontal pathogens, such as Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Bacteroides forsythus, Eikenella corrodens, and Eubacterium species, are motile. However, the technique may not provide detailed information about their specific characteristics or pathogenic potential.

2. Differentiation of Treponema Species:

   • Dark field microscopy cannot differentiate between species of Treponema, which is a limitation when identifying specific pathogens associated with periodontal disease. This lack of specificity can hinder the ability to tailor treatment based on the exact microbial profile.

3. Limited Quantitative Analysis:

   • While dark field microscopy allows for qualitative observations, it may not provide quantitative data on bacterial populations, which can be important for assessing disease severity and treatment outcomes.

Periodontal Medications and Their Uses

Periodontal medications play a crucial role in the management of periodontal diseases, aiding in the treatment of infections, inflammation, and tissue regeneration. Understanding the various types of medications and their specific uses is essential for effective periodontal therapy.

Types of Periodontal Medications

1. Antibiotics:

   • Uses:
     • Used to treat bacterial infections associated with periodontal disease.
     • Commonly prescribed antibiotics include amoxicillin, metronidazole, and doxycycline.
   • Mechanism:
     • They help reduce the bacterial load in periodontal pockets, promoting healing and reducing inflammation.

2. Antimicrobial Agents:

   • Chlorhexidine:
     • Uses: A topical antiseptic used as a mouth rinse to reduce plaque and gingivitis.
     • Mechanism: It disrupts bacterial cell membranes and inhibits bacterial growth.
   • Tetracycline:
     • Uses: Can be used topically in periodontal pockets to reduce bacteria.
     • Mechanism: Inhibits protein synthesis in bacteria, reducing their ability to cause infection.

3. Anti-Inflammatory Medications:

   • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs):
     • Uses: Used to manage pain and inflammation associated with periodontal disease.
     • Examples: Ibuprofen and naproxen.
   • Corticosteroids:
     • Uses: May be used in severe cases to reduce inflammation.
     • Mechanism: Suppress the immune response and reduce inflammation.

4. Local Delivery Systems:

   • Doxycycline Gel (Atridox):
     • Uses: A biodegradable gel that releases doxycycline directly into periodontal pockets.
     • Mechanism: Provides localized antibiotic therapy to reduce bacteria and inflammation.
   • Minocycline Microspheres (Arestin):
     • Uses: A localized antibiotic treatment that is placed directly into periodontal pockets.
     • Mechanism: Releases minocycline over time to combat infection.

5. Regenerative Agents:

   • Bone Grafts and Guided Tissue Regeneration (GTR) Materials:
     • Uses: Used in surgical procedures to promote the regeneration of lost periodontal tissues.
     • Mechanism: Provide a scaffold for new tissue growth and prevent the ingrowth of epithelium into the defect.

6. Desensitizing Agents:

   • Fluoride Varnishes:
     • Uses: Applied to sensitive areas to reduce sensitivity and promote remineralization.
     • Mechanism: Strengthens enamel and reduces sensitivity by occluding dentinal tubules.

Clinical Significance of Periodontal Medications

1. Management of Periodontal Disease:

   • Medications are essential in controlling infections and inflammation, which are critical for the successful treatment of periodontal diseases.

2. Adjunct to Non-Surgical Therapy:

   • Periodontal medications can enhance the effectiveness of non-surgical treatments, such as scaling and root planing, by reducing bacterial load and inflammation.

3. Surgical Interventions:

   • In surgical procedures, medications can aid in healing and regeneration, improving outcomes for patients undergoing periodontal surgery.

4. Patient Compliance:

   • Educating patients about the importance of medications in their treatment plan can improve compliance and overall treatment success.

Anatomy and Histology of the Periodontium

Gingiva (normal clinical appearance): no muscles, no glands; keratinized

• Color: coral pink but does vary with individuals and races due to cutaneous pigmentation
• Papillary contour: pyramidal shape with one F and one L papilla and the col filling interproximal space to the contact area (col the starting place gingivitis)
• Marginal contour: knife-edged and scalloped
• Texture: stippled (orange-peel texture); blow air to dry out and see where stippling ends to see end of gingiva
• Consistency: firm and resilient (push against it and won’t move); bound to underlying bone
• Sulcus depth: 0-3mm
• Exudate: no exudates (blood, pus, water)

  Anatomic and histological structures

Gingival unit: includes periodontium above alveolar crest of bone

a. Alveolar mucosa: histology- non-keratinized, stratified, squamous epithelium, submucosa with glands, loose connective tissue with collagen and elastin, muscles.  No epithelial ridges, no stratum granulosum (flattened cells below keratin layer)

b. Mucogingival junction: clinical demarcation between alveolar mucosa and attached gingiva

c. Attached gingiva: histology- keratinized, stratified, squamous epithelium with epithelial ridges (basal cell layer, prickle cell layer, granular cell layer (stratum granulosum), keratin layer); no submucosa

• Dense connective tissue: predominantly collagen, bound to periosteum of bone by Sharpey fibers
• Reticular fibers between collagen fibers and are continuous with reticulin in blood vessels

d. Free gingival groove: demarcation between attached and free gingiva; denotes base of gingival sulcus in normal gingiva; not always seen

e. Free gingival margin: area from free gingival groove to epithelial attachment (up and over ® inside)

• Oral surface: stratified, squamous epithelium with epithelial ridges
• Tooth side surface (sulcular epithelium): non-keratinized, stratified, squamous epithelium with no epithelial ridges (basal cell and prickle cell layers)

f. Gingival sulcus: space bounded by tooth surface, sulcular epithelium, and junctional epithelium; 0-3mm depth; space between epithelium and tooth

g. Dento-gingival junction: combination of epithelial and fibrous attachment

• Junctional epithelium (epithelial attachment): attachment of epithelial cells by hemi-desmosomes and sticky substances (basal lamina- 800-1200 A, DAS-acid mucopolysaccharides, hyaluronic acid, chondroitin sulfate A, C, and B), to enamel, enamel and cementum, or cementum depending on stage of passive eruption.  Length ranges from 0.25-1.35mm.
• Fibrous attachment: attachment of collagen fibers (Sharpey’s fibers) into cementum just beneath epithelial attachment; ~ 1mm thick

h. Nerve fibers: myelinated and non-myelinated (for pain) in connective tissue.  Both free and specialized endings for pain, touch pressure, and temperature -> proprioception.  If dentures, rely on TMJ.

i.Mesh of terminal argyophilic fibers (stain silver), some extending into epithelium

ii  Meissner-type corpuscles: pressure sensitive sensory nerve encased in CT

iii.Krause-type corpuscles: temperature receptors

iv. Encapsulated spindles

i. Gingival fibers:

i.  Gingivodental group:

• Group I (A): from cementum to free gingival margin
• Group II (B): from cementum to attached gingiva
• Group III (C): from cementum over alveolar crest to periosteum on buccal and lingual plates

ii.  Circular (ligamentum circularis): encircles tooth in free gingiva

iii. Transeptal fibers: connects cementum of adjacent teeth, runs over interdental septum of alveolar bone.  Separates gingival unit from attachment apparatus.

Transeptal and Group III fibers the major defense against stuff getting into bone and ligament.

2.  Attachment apparatus: periodontium below alveolar crest of bone

Periodontal ligament: Sharpey’s fibers (collagen) connecting cementum to bone (bundle bone).  Few elastic and oxytalan fibers associated with blood vessels and embedded in cementum in cervical third of tooth.  Components divided as follows:

i. Alveolar crest fibers: from cementum just below CEJ apical to alveolar crest of bone

ii.Horizontal fibers: just apical to alveolar crest group, run at right angles to long axis of tooth from cementum horizontally to alveolar bone proper

iii.Oblique fibers: most numerous, from cementum run coronally to alveolar bone proper

iv. Apical fibers: radiate from cementum around apex of root apically to alveolar bone proper, form socket base

v. Interradicular fibers: found only between roots of multi-rooted teeth from cementum to alveolar bone proper

vi. Intermediate plexus: fibers which splice Sharpey’s fibers from bone and cementum

vii. Epithelial Rests of Malassez: cluster and individual epithelial cells close to cementum which are remnants of Hertwig’s epithelial root sheath; potential source of periodontal cysts.

viii. Nerve fibers: myelinated and non-myelinated; abundant supply of sensory free nerve endings capable of transmitting tactile pressure and pain sensation by trigeminal pathway and elongated spindle-like nerve fiber for proprioceptive impulses

Cementum: 45-50% inorganic; 50-55% organic (enamel is 97% inorganic; dentin 70% inorganic)

i.  Acellular cementum: no cementocytes; covers dentin (older) in coronal ½ to 2/3 of root, 16-60 mm thick

ii. Cellular cementum: cementocytes; covers dentin in apical ½ to 1/3 of root; also may cover acellular cementum areas in repair areas, 15-200 mm thick

iii. Precementum (cementoid): meshwork of irregularly arranged collagen in surface of cementum where formation starts

iv. Cemento-enamel junction (CEJ): 60-65% of time cementum overlaps enamel; 30% meet end-to-end; 5-10% space between

v. Cementum slower healing than bone or PDL.  If expose dentinotubules ® root sensitivity.

Alveolar bone: 65% inorganic, 35% organic

i. Alveolar bone proper (cribriform plate): lamina dura on x-ray; bundle bone receive Sharpey fibers from PDL

ii. Supporting bone: cancellous, trabecular (vascularized) and F and L plates of compact bone

Blood supply to periodontium

i. Alveolar blood vessels (inferior and superior)

A) Interalveolar: actually runs through bone then exits, main supply to alveolar bone and PDL

B) Supraperiosteal: just outside bone, to gingiva and alveolar bone

C) Dental (pulpal): to pulp and periapical area

D) Terminal vessels (supracrestal): anastomose of A and B above beneath the sulcular epithelium

E) PDL gets blood from: most from branches of interalveolar blood vessels from alveolar bone marrow spaces, supraperiosteal vessels when interalveolar vessels not present, pulpal (apical) vessels, supracrestal gingival vessels

ii. Lymphatic drainage: accompany blood vessels to regional lymph nodes (esp. submaxillary group)

Connective Tissue of the Gingiva and Related Cellular Components

The connective tissue of the gingiva, known as the lamina propria, plays a crucial role in supporting the gingival epithelium and maintaining periodontal health. This lecture will cover the structure of the lamina propria, the types of connective tissue fibers present, the role of Langerhans cells, and the changes observed in the periodontal ligament (PDL) with aging.

Structure of the Lamina Propria

1. Layers of the Lamina Propria:

   • The lamina propria consists of two distinct layers:
     1. Papillary Layer:
        • The upper layer that interdigitates with the epithelium, containing finger-like projections that increase the surface area for exchange of nutrients and waste.
     2. Reticular Layer:
        • The deeper layer that provides structural support and contains larger blood vessels and nerves.

2. Types of Connective Tissue Fibers:

   • The lamina propria contains three main types of connective tissue fibers:

     1. Collagen Fibers:
        • Type I Collagen: Forms the bulk of the lamina propria and provides tensile strength to the gingival fibers, essential for maintaining the integrity of the gingiva.
     2. Reticular Fibers:
        • These fibers provide a supportive network within the connective tissue.
     3. Elastic Fibers:
        • Contribute to the elasticity and flexibility of the gingival tissue.

   • Type IV Collagen:

     • Found branching between the Type I collagen bundles, it is continuous with the fibers of the basement membrane and the walls of blood vessels.

Langerhans Cells

1. Description:

   • Langerhans cells are dendritic cells located among keratinocytes at all suprabasal levels of the gingival epithelium.
   • They belong to the mononuclear phagocyte system and play a critical role in immune responses.

2. Function:

   • Act as antigen-presenting cells for lymphocytes, facilitating the immune reaction.
   • Contain specific granules known as Birbeck’s granules and exhibit marked ATP activity.

3. Location:

   • Found in the oral epithelium of normal gingiva and in small amounts in the sulcular epithelium.
   • Absent from the junctional epithelium of normal gingiva.

Changes in the Periodontal Ligament (PDL) with Aging

1. Aging Effects:
   • With aging, several changes have been reported in the periodontal ligament:
     • Decreased Numbers of Fibroblasts: This reduction can lead to impaired healing and regeneration of the PDL.
     • Irregular Structure: The PDL may exhibit a more irregular structure, paralleling changes in the gingival connective tissues.
     • Decreased Organic Matrix Production: This can affect the overall health and function of the PDL.
     • Epithelial Cell Rests: There may be a decrease in the number of epithelial cell rests, which are remnants of the Hertwig's epithelial root sheath.
     • Increased Amounts of Elastic Fibers: This change may contribute to the altered mechanical properties of the PDL.

Periodontal Medicaments

Periodontal diseases often require adjunctive therapies to traditional mechanical treatments such as scaling and root planing. Various medicaments have been developed to enhance the healing process and control infection in periodontal tissues. This lecture will discuss several periodontal medicaments, their compositions, and their clinical applications.

1. Elyzol

• Composition:
  • Elyzol is an oil-based gel containing 25% metronidazole. It is formulated with glyceryl mono-oleate and sesame oil.
• Clinical Use:
  • Elyzol has been found to be equivalent to scaling and root planing in terms of effectiveness for treating periodontal disease.
  • However, no adjunctive effects beyond those achieved with mechanical debridement have been demonstrated.

2. Actisite

• Composition:

  • Actisite consists of tetracycline-containing fibers.
  • Each fiber has a diameter of 0.5 mm and contains 12.7 mg of tetracycline per 9 inches of fiber.

• Clinical Use:

  • The fibers are placed directly into periodontal pockets, where they release tetracycline over time, helping to reduce bacterial load and promote healing.

3. Arestin

• Composition:

  • Arestin contains minocycline, which is delivered as a biodegradable powder in a syringe.

• Clinical Use:

  • Arestin is indicated for the treatment of periodontal disease and is applied directly into periodontal pockets, where it provides localized antibiotic therapy.

4. Atridox

• Composition:

  • Atridox contains 10% doxycycline in a syringeable gel system that is biodegradable.

• Clinical Use:

  • The gel is injected into periodontal pockets, where it solidifies and releases doxycycline over time, aiding in the management of periodontal disease.

5. Dentamycin and Periocline

• Composition:

  • Both Dentamycin and Periocline contain 2% minocycline hydrochloride.

• Clinical Use:

  • These products are used similarly to other local delivery systems, providing localized antibiotic therapy to reduce bacterial infection in periodontal pockets.

6. Periochip

• Composition:

  • Periochip is a biodegradable chip that contains chlorhexidine.

• Clinical Use:

  • The chip is placed in the gingival crevice, where it releases chlorhexidine over time, providing antimicrobial action and helping to control periodontal disease.